Oceanía · Actualidad · The Advertiser (Adelaide Now)

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Publicado por The Advertiser (Adelaide Now) · Australia hace 15 h

CEO and Managing Director Dr Camile Farah to discuss the company’s US FDA 510(k) submission for its InForm digital pathology device, a major milestone towards potential US…

Leer el artículo completo en The Advertiser (Adelaide Now) Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.adelaidenow.com.au)

Long Shortz Optiscan: FDA submission opens path to US commercialisation

También te puede interesar

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Compartir

También te puede interesar

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

Revealed: Hawks’ opening offer for Merrett as trade war resumes

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns